British Columbia's drug decriminalization policy was associated with a substantial decrease in police encounters for drug possession, while neither decriminalization nor the subsequent partial recriminalization was associated ...
Sep 14, 2026
0
6
A new perspective from LSU's Pennington Biomedical Research Center proposes a new way of understanding how dietary protein restriction may promote healthy aging and extend lifespan: through a coordinated physiological response ...
Sep 13, 2026
0
330
Researchers at the Icahn School of Medicine at Mount Sinai have found that small populations of pancreatic cancer cells can create localized immune-protective niches that shield tumors from immune attack. The finding could ...
Sep 13, 2026
0
193
A new modeling study published in The Lancet suggests that U.S. Medicare's new "Most-Favored-Nation" pricing policy, which ties what Medicare pays for medicines to prices charged in other high-income countries, could push ...
Sep 13, 2026
0
40
Over the past few decades, antibody-based therapies have revolutionized modern medicine and are now widely used to treat cancer, autoimmune diseases, inflammatory disorders and even infectious diseases. Despite their success, ...
Sep 13, 2026
0
34
What makes the brain fall asleep? For nearly a century, scientists have looked to structures deep within the brain for the answer. In the traditional view, these regions control when we sleep and wake, while the cerebral ...
Sep 13, 2026
0
79
Researchers at Vanderbilt Health, UTHealth Houston and the University of North Carolina at Chapel Hill have identified early signs of cardiovascular-kidney-metabolic disease (CKMD) in children as young as 8 years old that ...
Sep 13, 2026
0
21
When women take part in breast cancer screening, they are informed that screening may detect cancers that would never have caused symptoms or problems during their lifetime. This is known as overdiagnosis.
Sep 13, 2026
0
165
Researchers have found a high level of agreement between cataract referral decisions based on smartphone images reviewed remotely and those made by ophthalmologists examining patients in person at rural eye camps.
Sep 13, 2026
0
221
New results from the global phase 1/2 ARROS-1 trial showed clinically meaningful activity with zidesamtinib in patients with advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) who had not previously received ...
Sep 13, 2026
0
7
